Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
GenScript Biotech Corp Insights
Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.
A sample of GenScript Biotech Corp Insights data
| Headline | Published | Journalists |
|---|---|---|
| Deserunt mollit sunt Lorem laborum do id aliqua dolore | 27 May 2022 | Lorem |
| Legend/Janssen’s CAR-T therapy asset cilta-cel potentially faces distribution, toxicity issues for multiple myeloma though FDA approval likely | 05 Nov 2021 | Adam Zamecnik |
| Nanjing Legend’s myeloma CAR-T yields comparable data to bluebird’s bb2121, but bluebird-Celgene partnership offers bigger boost – experts | 07 Jul 2017 | Alaric DeArment |
| Staurus employs GenScript for preclinical antibody manufacturing, signs licensing agreement - exec | 31 Aug 2016 | Alissa Fleck |
Feature
Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.
Benefit
Drug Insights:
- Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
- Material intelligence on competitors, including breaking news
- Insight on companies’ business development needs and strategies
Outsourcing Insights:
Insight on companies’ CRO and business development needs, strategies and relationships
Value
Remove risk and uncertainty
Gain a competitive edge
Secure actionable leads
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer